Pricing Log in Create free account

Nanobiotix S.A. - Sponsored ADR (NBTX) vs Replimune Group, Inc. (REPL)

Nanobiotix S.A. - Sponsored ADR and Replimune Group, Inc. are both Biotechnology companies. Nanobiotix S.A. - Sponsored ADR and Replimune Group, Inc. are of similar size ($1.1B and $1.1B). Across the 9 metrics below, Nanobiotix S.A. - Sponsored ADR leads on 7 and Replimune Group, Inc. on 2.

Valuation

Metric NBTX REPL Biotechnology median
P/E n/m n/m 8.50
P/S 4,254.38 n/m 9.71
P/B n/m 9.96 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3,498.88 n/m 9.21
Earnings yield (15.59%) (29.01%) (33.15%)
Free cash flow yield (19.65%) (26.67%) (25.50%)

Profitability

Metric NBTX REPL Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (134.29%) (56.36%)
Return on assets 0.00% (82.28%) (48.04%)
Return on invested capital 0.00% (1,154.69%) 0.00%

Growth

Metric NBTX REPL Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 63.46% (10.10%) 30.26%
Revenue growth, 5-year CAGR 66.64% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NBTX REPL Biotechnology median
Debt to equity 0.00 1.00 0.00
Current ratio 1.44 5.23 4.72
Net debt to EBITDA 5.66 0.51 0.96

Dividend

Metric NBTX REPL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NBTX REPL Biotechnology median
Market cap 1.13b 1.11b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack